Normal and Malignant Hematopoiesis: New Advances: Pezcoller Foundation Symposia, cartea 6
Editat de Enrico Mihich, Donald Metcalfen Limba Engleză Paperback – 21 noi 2012
Preț: 370.38 lei
Preț vechi: 389.88 lei
-5% Nou
Puncte Express: 556
Preț estimativ în valută:
70.87€ • 74.00$ • 58.52£
70.87€ • 74.00$ • 58.52£
Carte tipărită la comandă
Livrare economică 15-29 aprilie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781461357896
ISBN-10: 1461357896
Pagini: 260
Ilustrații: X, 249 p.
Dimensiuni: 178 x 254 x 14 mm
Greutate: 0.46 kg
Ediția:Softcover reprint of the original 1st ed. 1995
Editura: Springer Us
Colecția Springer
Seria Pezcoller Foundation Symposia
Locul publicării:New York, NY, United States
ISBN-10: 1461357896
Pagini: 260
Ilustrații: X, 249 p.
Dimensiuni: 178 x 254 x 14 mm
Greutate: 0.46 kg
Ediția:Softcover reprint of the original 1st ed. 1995
Editura: Springer Us
Colecția Springer
Seria Pezcoller Foundation Symposia
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
1. Regulation of Normal Hemopoiesis.- 2. Cytokine Regulation of Lymphohemopoietic Progenitors.- 3. Hematopoietic Stem Cells.- 4. Transcriptional Control of Hematopoietic Development: Roles of GATA-Factors.- 5. Rearrangement of the ALL1 Gene in Acute Myeloid Leukemia without Chromosomal Translocations.- 6. Non-Receptor Protein Tyrosine Kinases: Pivotal Regulatory Molecules Controlling Lymphopoiesis.- 7. The Regulation and Function of p21Ras in T Cell Activation and Growth.- 8. Irf-1 Functions as a Tumor Suppressor: Possible Involvement in Human Myelodysplasia and Leukemia.- 9. A Family of High Molecular Weight Proteins Active in Differentiation and Growth Control.- 10. Hematopoietic Signaling by the Cytokine Receptor Superfamily.- 11. Positive and Negative Growth Effects of Abl Genes.- 12. Advances in the Understanding of the Molecular Pathogenesis of Aggressive B Cell Lymphomas.- 13. Structure and Expression Pattern of the PML Gene.- 14. Contribution of the Cyclin D1 Gene to Lymphomagenesis.- 15. Clinical Results of All-trans Retinoic Acid: A Targeted Drug for Differentiation Treatment in Acute Promyelocytic Leukemia.- 16. Induction of Alloantigen Specific T Cell Anergy by Inhibition of the B7:CD28 Pathway.- 17. Novel Strategies for Cancer Treatment through Modulation of Proimmune and Proinflammatory Cytokines.- 18. Concluding Comments.